Check Claims Before You Publish

Author Review — Yanan Zhu

Concise visual summary followed by evidence-based critique, blindspots, and concrete improvement steps. Visualize first, explain second.

Representative high-quality biological papers (benchmarks)

Use these as methodological and data-sharing benchmarks when assessing biological claims (examples cited below provide high standards for data deposition, use of knockouts, multi-model validation, and code release).

• Cryo-ET chromatin fibres — in situ nucleosome mapping; EMDB deposition and GitHub code available Cryo-ET chromatin fibres (Nature Communications)
• Rg3–Blautia–SCFA–IFN axis — multi-model mouse immunology with sequencing + SRA deposits Rg3 — Blautia — IFN-I axis (ISME J)

Evidence-based assessment (what the data we have show)

1. Productivity & impact: Provided metadata lists 26 papers and ≈375 citations (h-index ≈8). This places the author in an early-to-mid career profile with modest citation impact relative to field leaders (h-index 25–40 benchmarks from OpenAlex examples). Claims about broad influence should be tempered by these metrics.
2. Topical heterogeneity: The paper list spans materials science, chemistry, engineering, energy storage, and several biomedical/clinical studies — suggesting either a multi-disciplinary profile or name ambiguities (common East-Asian name may conflate multiple authors). Name disambiguation is a major blindspot and must be resolved by ORCID/institutional affiliation checks before strong inferences.
3. Scientific rigor observed (from sample titles): Several papers appear experimental and domain-appropriate (e.g., materials, energy storage) but do not uniformly show the highest-level data-deposition and multi-model biological validation seen in the benchmark biological papers cited above. Biological claims (in the biomedical-titled papers) would benefit from explicit data sharing (SRA/EMDB), code, and detailed methods.

Each statement above is constrained by the supplied metadata and list of titles; full-text review of each paper (methods, data deposition, sample sizes, controls) is required for a definitive, paper-by-paper rigor assessment.

Concrete improvements for rising scientific strength

• Disambiguate author identity across databases: claim an ORCID and consistent institutional affiliation to avoid conflation with other "Yanan Zhu" entries; this raises trust and metric clarity.
• For biomedical/biological papers: deposit sequencing/omics datasets (SRA), raw imaging maps (EMDB/Zenodo), and analysis code (GitHub) to meet modern reproducibility norms (benchmarks illustrated above).
• Prefer focused topical programs per project — concentrating on either materials/energy or biological/clinical research increases domain expertise, citation depth, and methodological consistency.
• Use explicit causal models and multi-model validation (e.g., KO or orthogonal perturbations, replication cohorts) for biological claims to match high-evidence standards.

Blindspots, biases, and how to falsify core claims

Primary blindspots to correct or test:

• Name ambiguity bias: Confirm author identity (ORCID/institution) to avoid aggregating metrics from distinct individuals with the same name.
• Publication bias & selective reporting: Encourage pre-registration, full methods reporting, and deposition of negative results where relevant.
• Translational overreach: For any animal-based biological claim, require replication in independent cohorts, dose–response, and complementary human-relevant data before broad claims.

Falsification tests: failure to reproduce key experimental results in independent labs, lack of deposited raw data, or evidence of inconsistent author identity would reduce confidence substantially.

Quick verdict: The provided metadata indicates an author with modest impact and a heterogeneous publication portfolio; to robustly judge scientific strength we need (1) disambiguated identity (ORCID/institution), (2) per-paper method/ data checks, and (3) evidence of data/code deposition for biological claims. Current confidence in this review (given available metadata): 6/10.

Primary benchmark citations

Cryo-ET chromatin fibres: Cryo-ET chromatin fibres (Nature Communications)

Rg3 — microbiome — IFN axis: Rg3 — Blautia — IFN-I axis (ISME J)